Publications by authors named "David H Moore"

Claim this Profile
F
Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study.
Krishnansu S Tewari, Michael W Sill, Michael J Birrer, Richard T Penson, Helen Huang, David H Moore

Gynecol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062).
Krishnansu S Tewari, Michael W Sill, Bradley J Monk, Richard T Penson, David H Moore

Mol Cancer Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of pressure ulcers in Europe, what does the European data tell us: a systematic review.
Zena Moore, Pinar Avsar, Laura Conaty, David Hugh Moore, Declan Patton

J Wound Care· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Krishnansu S Tewari, Michael W Sill, Richard T Penson, Helen Huang, Lois M Ramondetta, David H Moore

Lancet· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
Kathleen N Moore, James J Java, Katrina N Slaughter, Peter G Rose, Rachelle Lanciano, David H Moore

Gynecol Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® Management of Recurrent Endometrial Cancer.
Mohamed A Elshaikh, Sean Vance, David K Gaffney, Matthew Biagioli, Anuja Jhingran, David H Moore

Am J Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® Adjuvant Management of Early-Stage Endometrial Cancer.
Andrew O Wahl, David K Gaffney, Anuja Jhingran, Catheryn M Yashar, Matthew Biagioli, David H Moore

Oncology (Williston Park)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study.
Krishnansu S Tewari, Michael W Sill, Bradley J Monk, Richard T Penson, Harry J Long, David H Moore

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer.
Shruti Jolly, Payal Soni, David K Gaffney, Matthew Biagioli, Mohamed A Elshaikh, David H Moore

Oncology (Williston Park)· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflections on vulvar tumors, lymphatic drainage, and sentinel lymph node biopsy.
David H Moore

Gynecol Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.
Cary Lynn Siegel, Rochelle F Andreotti, Higinia Rosa Cardenes, Douglas L Brown, David K Gaffney, David H Moore

J Am Coll Radiol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
Dana M Chase, Helen Q Huang, Lari Wenzel, David Cella, Richard McQuellon, David H Moore

Gynecol Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study.
David H Moore, Shamshad Ali, Wui-Jin Koh, Helen Michael, Mack N Barnes

Gynecol Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.
Pedro T Ramirez, Sarah Adams, John F Boggess, William M Burke, Michael M Frumovitz, David H Moore

Gynecol Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical staging of endometrial cancer: robotic versus open technique outcomes in a contemporary single surgeon series.
Meenu Goel, Terrell W Zollinger, David H Moore

J Robot Surg· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.
Jonathan S Berek, Eva Chalas, Mitchell Edelson, David H Moore, William M Burke

Obstet Gynecol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.
David H Moore, Chunqiao Tian, Bradley J Monk, Harry J Long, George A Omura

Gynecol Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: Are two therapies better than one?
David H Moore

Gynecol Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies.
Steven C Plaxe, Sandra E Brooks, Chunquiao Tian, Jeffrey D Bloss, David H Moore

Am J Obstet Gynecol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical staging and cervical cancer: after 30 years, have we reached a conclusion?
David H Moore

Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for advanced, recurrent, and metastatic cervical cancer.
David H Moore

J Natl Compr Canc Netw· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Agustin A Garcia, John A Blessing, Kathleen M Darcy, Heinz Josef Lenz, Wu Zhang, David H Moore

Gynecol Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study.
Steven E Waggoner, Kathleen M Darcy, Barbara Fuhrman, Groesbeck Parham, Joseph Lucci, David H Moore

Gynecol Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for recurrent cervical carcinoma.
David H Moore

Curr Opin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical cancer.
David H Moore

Obstet Gynecol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis